… to evaluate the pathologic status of breast cancer after treatment, including those of Chevallier
[33], Sataloff [34], the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-18 […

… (78%) responded no. The major reasons provided for nonadherence to recommended
guidelines … We document that academic breast pathology practices show significant variability in …

… National Surgical Adjuvant Breast and Bowel Project B-42 trial evaluated extended letrozole
therapy (ELT) in postmenopausal breast … Seven-year results demonstrated a nonstatistically …

… of surgical therapy has been a central theme in breast cancer research since the National
Surgical Adjuvant Breast and Bowel Project (NSABP) B-04 trial showed no advantage of a …

… RCTs, the National Surgical Adjuvant Breast and Bowel Project (NSABP) B… pathologic
examination of the axillary SLNs in patients with breast cancer have been influenced by the results …

… proposed by the National Surgical Adjuvant Breast and Bowel Project B-18, 4 Penault-Llorca …
as complete (or near-complete), partial, or no response. These methods may 29 or may not …

… surgical procedure of the primary site code to stratify patients who did and did not receive
surgical … and 3 patients and excluded missing pathologic T or N stage, path Tx or Nx and DCIS. …

… surgery after neoadjuvant chemotherapy (NAC) requires careful patient selection. We seek
to determine predictors of nodal pathologic … -negative breast cancer (TNBC), respectively. …

… January 1, 2011 to December 31, 2021 by clinical N status at diagnosis and pathologic N
status at surgery. Cochran-Armitage trend tests were calculated to evaluate patterns over time. …

… than 4 LNs in the final pathological specimen, whereas SLNB was defined as ≤ 4LNs.4 ,
7 … We used a national cohort of patients that included a large number of subjects: ideal for …